Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Sanofi and Regeneron pay $67.5m to speed alirocumab review Buy FDA priority review voucher from BioMarin.  . Sanofi and Regeneron Pharmaceuticals are paying $67.5m for an unusual licence which could enable them to get anti-cholesterol product alirocumab onto the ... We are very pleased that a patient population

AbbVie takes PARP inhibitor into third phase III trial

AbbVie takes PARP inhibitor into third phase III trial Other PARP inhibitors in clinical development include BioMarin's BMN 673 (phase III in breast cancer), Clovis Oncology's rupacarib (phase II in ovarian cancer) and Eisai's E7016 (phase II

Shire spells out why AbbVie takeover is a bad idea

Shire spells out why AbbVie takeover is a bad idea that the Irish company may be tempted into a defensive acquisition with the likes of Cubist or BioMarin.

EC approves Biomarin rare genetic disorder drug

EC approves Biomarin rare genetic disorder drug Vimizim now available to treat Morquio A syndrome. BioMarin has won EU approval to market its drug Vimizim for the rare genetic disorder Morquio A syndrome. ... This status provided BioMarin with certain development incentives and is down to the rarity

FDA backs BioMarin drug for rare enzyme disorder

FDA backs BioMarin drug for rare enzyme disorder BioMarin Pharmaceutical's Vimizim has become the first drug approved in the US to treat a rare genetic disorder that affects bone development, growth and mobility. ... BioMarin said it intends to begin promotion of the drug immediately in the US.

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Empowering the MS patient through shared decision making
Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered...
What pharma marketers can learn from Disney
Why we need to continue to innovate, and surprise our audience...
Good data is nothing without advocacy
...

Infographics